Video

The Heart Team at AHA 2022: Critical Care and Lipid Management, with On Chen, MD

With so many specialists dedicated to advancing the field, it hard to find a leading cardiologist not wearing a multitude of hats within their own institutions. Among these luminaries is On Chen, MD, of Stony Brook University.

At Stony Brook University and Stony Brook University Hospital, Chen serves as a clinical assistant professor of medicine and as the director of the Cardiac Intensive Care Unit and Telemetry Units, Outpatient Cardiology Services, and the Advanced Lipid Management program. Board-certified in internal medicine, interventional cardiology, nuclear cardiology, and echocardiography, Chen has gained a unique perspective and experience that leaves him uniquely qualified to provide practical insight and perspective on multiple aspects of the care continuum for patients with cardiovascular disease in real-world settings.

During their time on-site at the American Heart Association 2022 Scientific Sessions in Chicago, Il, The Heart Team hosts Jorge Plutzky, MD, director of preventive cardiology at Brigham and Women’s Hospital, and Michael Farkouh, MD, Peter Munk Chair in Multinational Clinical Trials at the Peter Munk Cardiac Centre, recorded 4 special edition episodes with leaders in cardiovascular medicine, including Chen. During their discussion with Chen, which occurred on day 2 of the 3-day meeting, our hosts learn more about how his professional passions have influenced his journey to his current roles at Stony Brook University. Chen also takes our hosts on a deep dive into the clinical processes at his institution, his prescribing preferences, and his perspective on some of the latest advances in lipidology.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
4 experts are featured in this series.
4 experts are featured in this series.
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.